ArticleCancer gene therapy2011

Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.

Y Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.